Welcome to our dedicated page for Rocket Lab Usa SEC filings (Ticker: RKLB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Rocket Lab Corporation filings document the public-company record for a launch services and space systems company whose common stock trades on Nasdaq under RKLB. Its 8-K reports disclose operating results, material agreements, acquisition activity, equity issuance matters, at-the-market and forward-sale arrangements, and other capital-structure events.
Proxy and governance filings cover annual meeting matters, stockholder proposals, director nomination procedures, executive compensation and stockholder voting items. The filing record also documents Rocket Lab’s common stock terms, liquidity disclosures tied to launch and space systems operations, and completed portfolio changes such as the Mynaric acquisition.
RKLB filed a Form 144 reporting proposed sales of Common Stock by Arjun Kampani. The filing lists transactions on 03/04/2026 and 03/02/2026 including a sale of 23,711 shares for $1,704,714.27 on 03/04/2026 and multiple dispositions on 03/02/2026 (for example, 16,792 shares for $1,175,965.59 and 5,284 shares for $365,142.37). The filing also shows earlier restricted stock vesting entries under a registered plan dated 03/13/2025, 08/22/2024, and 11/22/2024.
Rocket Lab Corp reported proposed resale activity on a Form 144 filed 05/27/2026. The filing shows 9,100 shares associated with Fidelity Brokerage Services LLC tied to a stock award (compensation) dated 08/22/2023. The filing also lists recent sales by Arjun L. Kampani: 28,761 shares on 03/02/2026 for $2,001,474.42 and 23,711 shares on 03/04/2026 for $1,662,852.43.
RKLB-related Form 144 notice: A broker/issuer record lists proposed sale activity tied to restricted stock vesting and a recent disposition by an individual. The entry shows $4,366,347.18 tied to 03/02/2026 and a vesting of 114,846 shares on 05/22/2026.
Morgan Stanley Smith Barney LLC submitted a Form 144 notice relating to proposed and recent sales of Common Stock for an account tied to compensation. The filing lists 81,250 shares tied to restricted stock vesting on 05/22/2026 and two past sales: 44,482 shares on 03/02/2026 and 36,768 shares on 03/04/2026.
Morgan Stanley Smith Barney LLC Executive Services filed a Rule 144 notice related to proposed resales of Common Stock tied to restricted stock vesting. The filing lists 38,685 and 13,787 shares with a 05/22/2026 vesting date under compensation. It also reports recent sales by Arjun Kampani of 21,135, 7,626, and 23,711 shares during March 2026 with dollar amounts shown.
Morgan Stanley Smith Barney LLC reported proposed sales of restricted common stock under Rule 144, listing 31,908 shares and 2,021 shares dated 05/22/2026 tied to restricted stock vesting. The filings identify the issuer as the counterparty and show transactions associated with compensation vesting on 05/22/2026.
Slusky Alexander R reported acquisition or exercise transactions in this Form 4 filing.
Rocket Lab Corp director Alexander R. Slusky reported an equity grant of 2,482 restricted stock units (RSUs). These RSUs were granted under Rocket Lab’s Amended and Restated Non-Employee Director Compensation Policy and the 2021 Stock Option and Incentive Plan as part of director compensation.
The RSUs will vest in full on the earlier of the company’s next Annual Meeting of Stockholders or the one-year anniversary of the grant date, subject to his continued board service. Following this grant, Slusky directly holds 61,331 shares of common stock and indirectly holds 434,675 shares through Abalone Cove LLLP, a partnership he and his spouse own.
Saintil Merline reported acquisition or exercise transactions in this Form 4 filing.
Rocket Lab Corp director Merline Saintil received a grant of 2,482 shares of Common Stock in the form of restricted stock units (RSUs). The RSUs were granted at no cash cost and increase her direct holdings to 264,385 shares. The RSUs will vest in full on the earlier of the company’s next annual meeting of stockholders or the one-year anniversary of the grant date, as long as she continues serving on the Board.
Possenriede Kenneth R reported acquisition or exercise transactions in this Form 4 filing.
Rocket Lab Corp director Kenneth R. Possenriede received an award of 2,482 shares of Common Stock in the form of restricted stock units. The grant was made at no cash cost to him and increases his direct holdings to 96,660 shares. These RSUs will vest in full on the earlier of the company’s next Annual Meeting of Stockholders or the one-year anniversary of the grant date, as long as he continues serving on the Board.
Olson Jon A reported acquisition or exercise transactions in this Form 4 filing.
Rocket Lab Corp director Jon A. Olson reported an equity grant of 2,482 restricted stock units (RSUs) of common stock at no cost. The RSUs were granted under Rocket Lab’s non-employee director compensation policy and 2021 equity plan on May 20, 2026. They will vest in full on the earlier of the company’s next annual meeting of stockholders or the one-year anniversary of the grant date, as long as Olson continues serving on the board. After this award, he directly holds 348,112 shares of Rocket Lab common stock.